微流体免疫检测市场规模、份额、成长分析，按产品、技术、应用、最终用户、地区划分 - 产业预测，2025 年至 2032 年

2023 年全球微流体免疫检测市场规模为 12 亿美元，预计将从 2024 年的 12.9 亿美元成长到 2032 年的 23.6 亿美元，预测期内（2025-2032 年）的复合年增长率为 7.8%。

微流体免疫检测市场正在经历快速成长，这得益于对具有成本效益、高照护现场诊断（POC）的需求不断增长，尤其是在资源有限的环境中。受人口变化和重症监护快速决策需求的推动，POC 测试在医院、诊所甚至家庭测试中变得越来越普遍。儘管目前存在诸如需要製备样品以及与现有仪器的结果不一致等挑战，但人们对能够以最少的试剂使用提供准确和定量结果的实验室晶片(LOC) 技术的兴趣日益浓厚。这一趋势受到大量创业投资投资、微流体技术的持续研究以及老龄化社会中慢性病日益流行的推动，使得 LOC 成为免疫诊断领域的游戏规则改变者。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究分析

微流体免疫检测市场规模（依产品）

• 市场概况
• 耗材
• 墨水匣
• 聚合物
• 玻璃
• 硅
• 试剂
• 系统

微流体免疫检测市场规模（依技术）

• 市场概况
• 电化学检测
• 光学检测

微流体免疫检测市场规模（依应用）

• 市场概况
• 心臟病学
• 单一生物标记检测
• 多重生物标记检测
• 感染疾病
• 肿瘤学
• 其他用途

微流体免疫检测市场规模（按最终用户划分）

• 市场概况
• 製药和生物技术公司
• 诊断实验室
• 医院
• 其他最终用户

微流体免疫检测市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Abbott Laboratories（US）
• Bio-Rad Laboratories（US）
• Becton, Dickinson and Company（US）
• Danaher Corporation（US）
• Fluidigm Corporation（US）
• GE Healthcare（US）
• Illumina Inc.（US）
• Luminex Corporation（US）
• Merck Millipore（Germany）
• PerkinElmer Inc.（US）
• Randox Laboratories Ltd.（UK）
• Roche Diagnostics（Switzerland）
• Siemens Healthineers AG（Germany）
• Thermo Fisher Scientific Inc.（US）
• Tosoh Corporation（Japan）
• Wako Pure Chemical Industries, Ltd.（Japan）
• Waters Corporation（US）

结论和建议

Global Microfluidic Immunoassay Market size was valued at USD 1.2 billion in 2023 and is poised to grow from USD 1.29 billion in 2024 to USD 2.36 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

The microfluidic immunoassay market is experiencing rapid growth, driven by the increasing demand for cost-effective, high-throughput point-of-care (POC) diagnostics, especially in resource-limited settings. POC tests are becoming more prevalent in hospitals, clinics, and even at-home testing, spurred by demographic changes and the need for faster decision-making in emergency care. Despite current challenges, such as the need for sample pre-treatment and inconsistent results from existing devices, there is rising interest in lab-on-a-chip (LOC) technology, which offers precise, quantitative results with minimal reagent use. This trend is bolstered by substantial venture capital investments, ongoing research in microfluidic technology, and the growing prevalence of chronic diseases among an aging population, positioning LOC as a game-changer in immunodiagnostics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microfluidic Immunoassay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microfluidic Immunoassay Market Segmental Analysis

Global Microfluidic Immunoassay Market is segmented by Product, Technology, Application, End User and region. Based on Product, the market is segmented into Consumables, Cartridges, Polymer, Glass, Silicon, Reagents and Systems. Based on Technology, the market is segmented into Electrochemical Detection and Optical Detection. Based on Application, the market is segmented into Cardiology, Single Biomarker Detection, Multiplexed Biomarker Detection, Infectious Diseases, Oncology and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, Hospital and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Microfluidic Immunoassay Market

The microfluidic immunoassay market is poised for significant growth driven by the advent of innovative technologies and the potential of emerging economies. The introduction of novel advancements, such as paper-based microfluidics, is expected to unlock numerous growth opportunities for industry players. Boosted by factors like an aging population, a large patient base with infectious and non-communicable diseases, increased funding for research and development, and a heightened demand for quality healthcare services, these economies are witnessing substantial progress. Furthermore, rising disposable incomes and enhanced healthcare infrastructure are contributing to the market's expansion, creating an optimistic outlook for the sector.

Restraints in the Global Microfluidic Immunoassay Market

The Global Microfluidic Immunoassay market faces various restraints that could impede its growth, particularly in developing nations. Key challenges include the difficulty in selecting appropriate substrate materials for microfluidic chip fabrication, securing reimbursement for these technologies, and scaling up production for widespread availability. Additionally, the lack of affordable options poses a significant barrier, as low-cost products are essential for adoption in underdeveloped regions. These issues contribute to limited accessibility and availability, ultimately hindering the overall market potential in countries where healthcare resources are constrained. Addressing these challenges will be crucial for the market's expansion.

Market Trends of the Global Microfluidic Immunoassay Market

The Global Microfluidic Immunoassay market is witnessing a significant upward trend, driven by the increasing adoption of lab-on-a-chip (LOC) technologies that streamline diagnostic processes by integrating multiple laboratory functions onto a compact platform. This shift eliminates the necessity for cumbersome equipment, enhancing accessibility and efficiency, particularly in point-of-care (POC) settings. Furthermore, the popularity of paper-based microfluidics is rising, especially in developing regions, due to its cost-effectiveness, versatility, and reliance on capillary action for fluid management. With extensive commercial and academic research advancing this field, the market is poised for substantial growth as it increasingly supports rapid diagnostics and personalized medicine.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global Microfluidic Immunoassay Market Size by Product & CAGR (2025-2032)

• Market Overview
• Consumables
• Cartridges
• Polymer
• Glass
• Silicon
• Reagents
• Systems

Global Microfluidic Immunoassay Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Electrochemical Detection
• Optical Detection

Global Microfluidic Immunoassay Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cardiology
• Single Biomarker Detection
• Multiplexed Biomarker Detection
• Infectious Diseases
• Oncology
• Other Applications

Global Microfluidic Immunoassay Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Diagnostic Laboratories
• Hospital
• Other End Users

Global Microfluidic Immunoassay Market Size & CAGR (2025-2032)

• North America (Product, Technology, Application, End User)
  • US
  • Canada
• Europe (Product, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Millipore (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tosoh Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wako Pure Chemical Industries, Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Waters Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations